logo
Sign InSign Up

BAXTER INTERNATIONAL INC (BAX)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for BAX, sign up here.

Income Statement

Revenue

$14.8bn

Gross Profit

$5.0bn

Earning before Tax

$2.6bn

Net Income

$2.7bn

Net Income Common Shareholders

$2.7bn

EPS

5.25

Balance Sheet

Cash

$3.2bn

Debt

$14.2bn

Assets

$28.3bn

Liabilities

$19.8bn

Equity

$8.4bn

Enterprise Value

$30.8bn

Cash Flow Statement

Net Cash from Operations

$1.7bn

Net Cash from Investing

$3.2bn

Net Cash from Financing

$-3.5bn

Net Cash Flow

$1.5bn

Free Cash Flow

$1.0bn

Free Cash Flow per Share

$2.04

Metrics

Price to Equity

7.38

Price to Equity (Damodaran)

7.36

Price to Book

2.33

Net Margin

0.18

Return on Equity

0.38

Return on Sales

0.21

Get immediate access to 5-years of reference grade data for BAX for free.

Sign up

Company Profile

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company''s products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors'' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Company Info

Industry

Medical Instruments & Supplies

Employees

60,000

Address

One Baxter Parkway
Deerfield, IL 60015
United States

Phone

224 948 2000

Last Updated

2024-02-16

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy